BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 30772776)

  • 1. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
    Morean ME; Lederman IR
    Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping cannabis potency in medical and recreational programs in the United States.
    Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
    PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana use among patients with epilepsy at a tertiary care center.
    Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
    Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.
    Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA
    Front Public Health; 2022; 10():893009. PubMed ID: 35784239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
    Dunbar MS; Seelam R; Tucker JS; Firth CL; Pedersen ER; Klein DJ; Rodriguez A; D'Amico EJ
    Addict Behav; 2022 Mar; 126():107185. PubMed ID: 34839070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
    Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
    Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis in Parkinson's Disease: The Patients' View.
    Yenilmez F; Fründt O; Hidding U; Buhmann C
    J Parkinsons Dis; 2021; 11(1):309-321. PubMed ID: 33216043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent Δ8-THC and Marijuana Use in the US.
    Harlow AF; Miech RA; Leventhal AM
    JAMA; 2024 Mar; 331(10):861-865. PubMed ID: 38470384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries.
    Tanco K; Olson A; Fellman B; Jankowski M; Lai SY; Shete S; Harbison K; Scheid J; Bruera E
    J Palliat Med; 2023 Nov; 26(11):1482-1487. PubMed ID: 37285183
    [No Abstract]   [Full Text] [Related]  

  • 14. [CHARACTERISTICS OF MEDICAL CANNABIS USAGE AMONG PATIENTS WITH FIBROMYALGIA].
    Habib G; Levinger U
    Harefuah; 2020 May; 159(5):343-348. PubMed ID: 32431124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.
    Pacula RL; Jacobson M; Maksabedian EJ
    Addiction; 2016 Jun; 111(6):973-80. PubMed ID: 26687431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain.
    Boehnke KF; Scott JR; Litinas E; Sisley S; Clauw DJ; Goesling J; Williams DA
    J Pain; 2019 Nov; 20(11):1362-1372. PubMed ID: 31132510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Twitter-based survey on marijuana concentrate use.
    Daniulaityte R; Zatreh MY; Lamy FR; Nahhas RW; Martins SS; Sheth A; Carlson RG
    Drug Alcohol Depend; 2018 Jun; 187():155-159. PubMed ID: 29669296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.
    Williams AR; Santaella-Tenorio J; Mauro CM; Levin FR; Martins SS
    Addiction; 2017 Nov; 112(11):1985-1991. PubMed ID: 28600874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis for Chronic Pain: Challenges and Considerations.
    Romero-Sandoval EA; Fincham JE; Kolano AL; Sharpe BN; Alvarado-Vázquez PA
    Pharmacotherapy; 2018 Jun; 38(6):651-662. PubMed ID: 29637590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of the use of cannabidiol-related products in a safety-sensitive drug testing environment: A medical-legal perspective.
    Jooste J; Laurens JB; Jordaan M; Marais AAS; Curlewis LG
    S Afr Med J; 2021 Oct; 111(10):942-945. PubMed ID: 34949286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.